Role of left ventricular scar and purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 3, 2009, Pages 286-290

  Sinha, Anil Martin ^a   Schmidt, Martin ^a   Marschang, Harald ^a   Gutleben, Klaus ^a   Ritscher, Guido ^a   Brachmann, Johannes ^a   Marrouche, Nassir F ^b,c  

^a KLINIKUM COBURG   (Germany)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Catheter ablation; Dilated cardiomyopathy; Electroanatomical mapping; Implantable cardioverter defibrillator; Purkinje like potentials; Ventricular fibrillation

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOPRENALINE;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SCAR; HEART MUSCLE POTENTIAL; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; PURKINJE FIBER; RECURRENT DISEASE;

ACTION POTENTIALS; AGED; ANIMALS; BODY SURFACE POTENTIAL MAPPING; CARDIOMYOPATHY, DILATED; CATHETER ABLATION; CICATRIX; FEMALE; HEART VENTRICLES; HUMANS; MALE; PURKINJE FIBERS; VENTRICULAR FIBRILLATION;

EID: 61449239269     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.02233.x     Document Type: Article

References (16)

1. Bansch D, Bocker D, Brunn J, Weber M, Breithardt G, Block M. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol 2000 36 : 566 573.
2. Haissaguerre M, Shah DC, Jais P, Shoda M, Kautzner J, Arentz T, Kalusche D, et al. Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet 2002 359 : 677 678.
3. Haissaguerre M, Shoda M, Jais P, Nogami A, Shah DC, Kautzner J, Arentz T, et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation 2002 106 : 962 967.
4. Nogami A, Sugiyasu A, Kubota S, Kato K. Mapping and ablation of idiopathic ventricular fibrillation from the Purkinje system. Heart Rhythm 2005 2 : 646 649.
5. Haissaguerre M, Extramiana F, Hocini M, Cauchemez B, Jais P, Cabrera JA, Fare J, et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation 2003 108 : 925 928.
6. Mlcochova H, Saliba WI, Burkhardt DJ, Rodriguez RE, Cummings JE, Lakkireddy D, Patel D, et al. Catheter ablation of ventricular fibrillation storm in patients with infiltrative amyloidosis of the heart. J Cardiovasc Electrophysiol 2006 17 : 426 430.
7. Marrouche NF, Verma A, Wazni O, Schweikert R, Martin DO, Saliba W, Kilicaslan F, et al. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol 2004 43 : 1715 1720.
8. Bansch D, Oyang F, Antz M, Arentz T, Weber R, Val-Mejias JE, Ernst S, et al. Successful catheter ablation of electrical storm after myocardial infarction. Circulation 2003 108 : 3011 3016.
9. Pak HN, Kim YH, Lim HE, Chou CC, Miyauchi Y, Fang YH, Sun K, et al. Role of the posterior papillary muscle and Purkinje potentials in the mechanism of ventricular fibrillation in open chest dogs and swine: Effects of catheter ablation. J Cardiovasc Electrophysiol 2006 17 : 777 783.
10. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000 101 : 1288 1296.
11. Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 2003 108 : 704 710.
12. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL, Meininger, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005 112 : 2821 2825.
13. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003 108 : 1945 1953.
14. O'Neill JO, McCarthy PM, Brunken RC, Buda T, Hoercher K, Young JB, Starling RC. PET abnormalities in patients with nonischemic cardiomyopathy. J Card Fail 2004 10 : 244 249.
15. Cesario DA, Vaseghi M, Boyle NG, Fishbein MC, Valderrabano M, Narasimhan C, Wiener I, et al. Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia. Heart Rhythm 2006 3 : 1 10.
16. Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: The importance of low-voltage scars. J Am Coll Cardiol 2004 43 : 1834 1842.